Adma Biologics Inc organizacji EPS Q/Q
Jaka jest wartość EPS Q/Q organizacji Adma Biologics Inc?
Wartość EPS Q/Q organizacji Adma Biologics Inc to -38.46%
Jaka jest definicja EPS Q/Q?
Perspektywiczna kwartalna stopa wzrostu (Quarterly EPS growth rate) to szacowany wzrost wartości EPS w ujęciu kwartalnym za ostatnie cztery kwartały w porównaniu z wynikami z ostatnich czterech kwartałów.
The earnings per share growth rate is an important factor for judging a company's value. EPS growth rate gives a good picture of the rate at which the company has grown its profitability in respect to the total number of shares. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
EPS Q/Q firm w Health Care sektor na NASDAQ w porównaniu do Adma Biologics Inc
Czym się zajmuję organizacja Adma Biologics Inc?
adma is a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the treatment and prevention of primary immune deficiency disease (pidd) and certain infectious diseases. adma's mission is to develop and commercialize plasma-derived, human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases. the target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease, or who may be immune-compromised for medical reasons. adma’s lead product candidate, ri-002, has completed a phase iii clinical trial in patients with pidd and has met the primary endpoint. a bla for ri-002 was accepted by the fda on september 18, 2015. the company has received u.s. patent 9,107,906. for more information, please visit the company's website at www.admabiologics.com.
Firmy z eps q/q podobne do Adma Biologics Inc
- Wartość EPS Q/Q organizacji Akzo Nobel NV to -38.71%
- Wartość EPS Q/Q organizacji Aeglea BioTherapeutics Inc to -38.71%
- Wartość EPS Q/Q organizacji InflaRx N.V to -38.71%
- Wartość EPS Q/Q organizacji GE Aerospace to -38.60%
- Wartość EPS Q/Q organizacji Semler Scientific to -38.55%
- Wartość EPS Q/Q organizacji First Foundation Inc to -38.55%
- Wartość EPS Q/Q organizacji Adma Biologics Inc to -38.46%
- Wartość EPS Q/Q organizacji J&J Snack Foods to -38.41%
- Wartość EPS Q/Q organizacji Stemline Therapeutics to -38.36%
- Wartość EPS Q/Q organizacji Black Diamond Therapeutics Inc to -38.14%
- Wartość EPS Q/Q organizacji AngloGold Ashanti Plc to -38.10%
- Wartość EPS Q/Q organizacji Franklin Resources to -38.10%
- Wartość EPS Q/Q organizacji Allena Pharmaceuticals Inc to -38.10%